American Academy of Ophthalmology (AAO) recommend using NSAIDs only in high-risk cases, such as diabetic retinopathy.56
The National Institute for Health and Care Excellence (NICE) recommends to consider using a combination of topical steroids and NSAIDs after cataract surgery for people with increased risk of PCMO, for example, patients with diabetes or uveitis. Topical steroids and/or NSAIDs may be offered after cataract surgery to prevent inflammation and PCMO.57
The Canadian Ophthalmology Society recommends using topical steroids, NSAIDs or both in all intraocular surgery.
Cochrane Libraray: „Möglicherweise Reduktion des Risikos vom CMÖ durch NSARs Monotherapie oder in Kombination mit Steroide im Vergleich mit Steroide Monotherapie (niedriger Evidenzgrad) = keine Empfehlung nach unkomplizierter Katarakt-OP möglich“. (2017)
